Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Li Di. (2023) Recent advances in measurement of metabolic clearance, metabolite profile and reaction phenotyping of low clearance compounds. Expert Opinion on Drug Discovery 18:11, pages 1209-1219.
Read now
Read now
Xueting Xing, Mengzhu Kong, Qiaoyu Hou, Jiaqi Li, Wen Qian, Xijing Chen, Hanhan Li & Changqing Yang. (2022) Effects of ginkgo leaf tablet on the pharmacokinetics of rosiglitazone in rats and its potential mechanism. Pharmaceutical Biology 60:1, pages 1190-1197.
Read now
Read now
Mizuki Yamane, Fumihiko Igarashi, Tsuyoshi Yamauchi & Toshito Nakagawa. (2021) Main contribution of UGT1A1 and CYP2C9 in the metabolism of UR-1102, a novel agent for the treatment of gout. Xenobiotica 51:1, pages 61-71.
Read now
Read now
Kanami Shimura, Norie Murayama, Saki Tanaka, Shunsuke Onozeki & Hiroshi Yamazaki. (2019) Suitable albumin concentrations for enhanced drug oxidation activities mediated by human liver microsomal cytochrome P450 2C9 and other forms predicted with unbound fractions and partition/distribution coefficients of model substrates. Xenobiotica 49:5, pages 557-562.
Read now
Read now
Articles from other publishers (33)
Maike Felipe Santos Barbetta, Icaro Salgado Perovani, Leandro Oka Duarte & Anderson Rodrigo Moraes de Oliveira. (2023) Enantioselective in vitro metabolism of the herbicide diclofop-methyl: Prediction of toxicokinetic parameters and reaction phenotyping. Journal of Pharmaceutical and Biomedical Analysis 235, pages 115639.
Crossref
Crossref
Ikuo Yamamiya, Allen Hunt, Toru Takenaka, Daryl Sonnichsen, Mark Mina, Yaohua He, Karim A. Benhadji & Ling Gao. (2023) Evaluation of the Cytochrome P450 3A and P‐glycoprotein Drug‐Drug Interaction Potential of Futibatinib. Clinical Pharmacology in Drug Development.
Crossref
Crossref
Yan Weng, Kari R. Fonseca, Yi-an Bi, Sumathy Mathialagan, Keith Riccardi, Elaine Tseng, Andrew J. Bessire, Mathew A. Cerny, David A. Tess, A. David Rodrigues, Amit S. Kalgutkar, John Litchfield, Li Di & Manthena V. S. Varma. (2022) Transporter-Enzyme Interplay in the Pharmacokinetics of PF-06835919, a First-In-Class Ketohexokinase Inhibitor for Metabolic Disorders and Nonalcoholic Fatty Liver Disease. Drug Metabolism and Disposition 50:9, pages 1312-1321.
Crossref
Crossref
Poonam Giri, Lakshmikant Gupta, Anil Rathod, Vipul Joshi, Shyamkumar Giri, Nirmal Patel, Sameer Agarwal & Mukul R Jain. (2022) ZY12201: A Potent TGR5 Agonist: Identification of a Novel Pan CYP450
Inhibitor Tool Compound for In-Vitro Assessment. Drug Metabolism and Bioanalysis Letters 15:2, pages 116-132.
Crossref
Crossref
Yurong Lai, Xiaoyan Chu, Li Di, Wei Gao, Yingying Guo, Xingrong Liu, Chuang Lu, Jialin Mao, Hong Shen, Huaping Tang, Cindy Q. Xia, Lei Zhang & Xinxin Ding. (2022) Recent advances in the translation of drug metabolism and pharmacokinetics science for drug discovery and development. Acta Pharmaceutica Sinica B 12:6, pages 2751-2777.
Crossref
Crossref
Parthena Martin, Maciej Czerwiński, Pallavi B. Limaye, Brian W. Ogilvie, Steven Smith & Brooks Boyd. (2022) In vitro evaluation suggests fenfluramine and norfenfluramine are unlikely to act as perpetrators of drug interactions. Pharmacology Research & Perspectives 10:3.
Crossref
Crossref
L. Ward, Philip Butler & Robert J. Riley. 2022. The ADME Encyclopedia. The ADME Encyclopedia
631
641
.
J. Wilcock & L. Ward. 2022. The ADME Encyclopedia. The ADME Encyclopedia
379
387
.
Philip Butler & Robert J. Riley. 2022. The ADME Encyclopedia. The ADME Encyclopedia
537
547
.
Erickson M. Paragas, Zeyuan Wang, Ken Korzekwa & Swati Nagar. (2021) Complex Cytochrome P450 Kinetics Due to Multisubstrate Binding and Sequential Metabolism. Part 2. Modeling of Experimental Data. Drug Metabolism and Disposition 49:12, pages 1100-1108.
Crossref
Crossref
Sheri Smith, Michael Lyman, Bennett Ma, Donald Tweedie & Karsten Menzel. (2021) Reaction Phenotyping of Low-Turnover Compounds in Long-Term Hepatocyte Cultures Through Persistent Selective Inhibition of Cytochromes P450. Drug Metabolism and Disposition 49:11, pages 995-1002.
Crossref
Crossref
Kefeng Sun & Devin Welty. (2021) Elucidation of Metabolic and Disposition Pathways for Maribavir in Nonhuman Primates through Mass Balance and Semi–Physiologically Based Modeling Approaches. Drug Metabolism and Disposition 49:11, pages 1025-1037.
Crossref
Crossref
Eric Gonzalez, Sankalp Jain, Pranav Shah, Nao Torimoto-Katori, Alexey Zakharov, Ðắc-Trung Nguyễn, Srilatha Sakamuru, Ruili Huang, Menghang Xia, R. Scott Obach, Cornelis E. C. A. Hop, Anton Simeonov & Xin Xu. (2021) Development of Robust Quantitative Structure-Activity Relationship Models for CYP2C9, CYP2D6, and CYP3A4 Catalysis and Inhibition. Drug Metabolism and Disposition 49:9, pages 822-832.
Crossref
Crossref
Lei Feng, Jing Ning, Xiangge Tian, Chao Wang, Zhenlong Yu, Xiaokui Huo, Tian Xie, Baojing Zhang, Tony D. James & Xiaochi Ma. (2021) Fluorescent probes for the detection and imaging of Cytochrome P450. Coordination Chemistry Reviews 437, pages 213740.
Crossref
Crossref
Donald J. AbrahamEdward H. Kerns, Xun Zhang & Li Di. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
1
31
.
Saraswathisreeram Pranush Kumar, Deeki Doma Sherpa, Amit Kumar Sahu, Tarang Jadav, Rakesh Kumar Tekade & Pinaki Sengupta. (2021)
Innovation in bioanalytical strategies and
in vitro
drug–drug interaction study approaches in drug discovery
. Bioanalysis 13:6, pages 513-532.
Crossref
Crossref
Yaru Peng, Zeneng Cheng & Feifan Xie. (2021) Evaluation of Pharmacokinetic Drug–Drug Interactions: A Review of the Mechanisms, In Vitro and In Silico Approaches. Metabolites 11:2, pages 75.
Crossref
Crossref
Li Di, Amanda Balesano, Samantha Jordan & Sophia M. Shi. (2021) The Role of Alcohol Dehydrogenase in Drug Metabolism: Beyond Ethanol Oxidation. The AAPS Journal 23:1.
Crossref
Crossref
L. Ward, P. Butler & R. Riley. 2021. The ADME Encyclopedia. The ADME Encyclopedia
1
11
.
J. Wilcock & L. Ward. 2021. The ADME Encyclopedia. The ADME Encyclopedia
1
9
.
Philip Butler & Robert J. Riley. 2021. The ADME Encyclopedia. The ADME Encyclopedia
1
11
.
Ken Korzekwa. 2021. Enzyme Kinetics in Drug Metabolism. Enzyme Kinetics in Drug Metabolism
237
256
.
Susan Wong & Zhengyin Yan. 2021. Cytochrome P450. Cytochrome P450
291
305
.
Kimberly Lapham, Ernesto Callegari, Julie Cianfrogna, Jian Lin, Mark Niosi, Christine C. Orozco, Raman Sharma & Theunis C. Goosen. (2020) In Vitro Characterization of Ertugliflozin Metabolism by UDP-Glucuronosyltransferase and Cytochrome P450 Enzymes. Drug Metabolism and Disposition 48:12, pages 1350-1363.
Crossref
Crossref
Bingjie Hu, Xin Zhou, Michael A. Mohutsky & Prashant V. Desai. (2020) Structure–Property Relationships and Machine Learning Models for Addressing CYP3A4-Mediated Victim Drug–Drug Interaction Risk in Drug Discovery. Molecular Pharmaceutics 17:9, pages 3600-3608.
Crossref
Crossref
Tom S. Chan, Young-Sun Scaringella, Klairynne Raymond & Mitchell E. Taub. (2020) Evaluation of Erythromycin as a Tool to Assess CYP3A Contribution of Low Clearance Compounds in a Long-Term Hepatocyte Culture. Drug Metabolism and Disposition 48:8, pages 690-697.
Crossref
Crossref
Shin-ichiro Ogawa, Makiko Shimizu, Yusuke Kamiya, Shotaro Uehara, Hiroshi Suemizu & Hiroshi Yamazaki. (2020) Increased plasma concentrations of an antidyslipidemic drug pemafibrate co-administered with rifampicin or cyclosporine A in cynomolgus monkeys genotyped for the organic anion transporting polypeptide 1B1. Drug Metabolism and Pharmacokinetics 35:4, pages 354-360.
Crossref
Crossref
Emi Kimoto, R. Scott Obach & Manthena V.S. Varma. (2020) Identification and quantitation of enzyme and transporter contributions to hepatic clearance for the assessment of potential drug-drug interactions. Drug Metabolism and Pharmacokinetics 35:1, pages 18-29.
Crossref
Crossref
Chuang Lu & Li Di. (2020)
In vitro
and
in vivo
methods to assess pharmacokinetic drug– drug interactions in drug discovery and development
. Biopharmaceutics & Drug Disposition 41:1-2, pages 3-31.
Crossref
Crossref
Ren-Jong Liang, Yin-Ning Shih, Yen-Lun Chen, Wei-Yang Liu, Wan-Ling Yang, Shih-Yu Lee & Hong-Jaan Wang. (2020) A dual system platform for drug metabolism: Nalbuphine as a model compound. European Journal of Pharmaceutical Sciences 141, pages 105093.
Crossref
Crossref
Adrian J. Fretland, Tashinga E. Bapiro, Barry Jones, Roshini Markandu, Alexandra L. Orton & Venkatesh Pilla Reddy. 2020. Identification and Quantification of Drugs, Metabolites, Drug Metabolizing Enzymes, and Transporters. Identification and Quantification of Drugs, Metabolites, Drug Metabolizing Enzymes, and Transporters
213
236
.
Xin Yang, Sangwoo Ryu & Li Di. (2019) Dasotraline as a selective cytochrome 2B6 inhibitor for reaction phenotyping. Biopharmaceutics & Drug Disposition 40:9, pages 358-361.
Crossref
Crossref
Jarkko Rautio, Nicholas A. Meanwell, Li Di & Michael J. Hageman. (2018) The expanding role of prodrugs in contemporary drug design and development. Nature Reviews Drug Discovery 17:8, pages 559-587.
Crossref
Crossref